NAD+ / NMN / NR

Origin & Background

The molecule at the centre of cellular energy

Nicotinamide adenine dinucleotide (NAD+) is one of the most fundamental molecules in biology. Every living cell uses it — as an electron carrier in energy metabolism (shuttling electrons in glycolysis and the TCA cycle to generate ATP), as a substrate for sirtuin enzymes (the "longevity proteins" that regulate gene expression, DNA repair, and stress responses), and as a substrate for PARP enzymes (which repair DNA damage). Without NAD+, cellular energy production stops entirely.

NAD+ levels decline reliably with age — estimated to fall by 50% between young adulthood and midlife in many tissues. This decline is now considered a potential primary driver of many hallmarks of ageing: mitochondrial dysfunction, impaired DNA repair, reduced sirtuin activity, and increased inflammation. Restoring NAD+ has become one of the most studied longevity interventions.

Direct NAD+ supplementation has poor oral bioavailability. The more effective approach is supplementing with precursors that the body converts into NAD+. The two most studied are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — both members of the vitamin B3 family, both available as supplements, and both with a growing human clinical trial base. The David Sinclair (Harvard) research programme brought these compounds to mainstream awareness from 2013 onward.

NMN vs NR vs Niacin: NMN is one step closer to NAD+ in the biosynthetic pathway and may have superior tissue uptake in some contexts. NR requires conversion to NMN before becoming NAD+. Both have shown NAD+ elevation in human trials. Niacin (nicotinic acid) is the cheapest precursor and also raises NAD+ but causes the well-known "niacin flush" (prostaglandin-mediated vasodilation). Nicotinamide (plain niacinamide) raises NAD+ but inhibits sirtuins at high doses — a significant concern. For longevity applications, NMN or NR are preferred.

Science & Mechanism

Sirtuin activation, DNA repair, and mitochondria

How NAD+ Precursors Work

Conversion to NAD+: NMN → NAD+ via NMNAT enzymes. NR → NMN → NAD+ via NRK kinases. Both raise intracellular and blood NAD+ levels consistently in human trials — confirmed in multiple RCTs from 2022 onward.

Sirtuin activation (SIRT1–7): Sirtuins are NAD+-dependent deacetylases that regulate gene expression, stress responses, mitochondrial biogenesis, and inflammation. They require NAD+ as a co-substrate — without sufficient NAD+, sirtuin activity falls. Restoring NAD+ reactivates sirtuin function.

PARP activation — DNA repair: PARP enzymes detect and repair DNA strand breaks, consuming NAD+ in the process. As DNA damage accumulates with age, PARP activity increases — competing with sirtuins for NAD+. NMN/NR supplementation provides NAD+ for both systems.

Mitochondrial biogenesis: Sirtuin 1 (SIRT1) activates PGC-1α — the master regulator of mitochondrial biogenesis. Raising NAD+ → activating SIRT1 → activating PGC-1α → more mitochondria → better energy production. This is the chain linking NAD+ to exercise performance and metabolic health.

Anti-inflammatory via NF-κB suppression: NAD+-fueled sirtuin activity suppresses NF-κB — the key inflammatory transcription factor. This reduces pro-inflammatory cytokines. NR supplementation in older humans has been shown to reduce inflammatory markers significantly.

Human clinical evidence has expanded substantially since 2021. The pivotal Yoshino et al. (2022) trial showed 250mg/day NMN for 10 weeks in overweight women with prediabetes significantly improved muscle insulin sensitivity by 25% — the gold-standard euglycaemic clamp measurement. NMN also raised NAD+ in muscle, reduced fat mass, and improved muscle gene expression. A 2023 RCT showed NMN supplementation significantly reduced total LDL and non-HDL cholesterol, body weight, and diastolic blood pressure. Multiple trials have confirmed oral NMN reliably raises blood NAD+ levels in humans.

A 2024 GeroScience RCT of NMN in older adults showed increased blood NAD+ levels, maintained walking speed, and improved sleep quality. The 2025 meta-analysis (Prokopidis et al., J Cachexia Sarcopenia Muscle) confirmed that NMN and NR supplementation improved skeletal muscle mass and function. The 2025 systems approach trial (Nature npj Aging) showed that targeting multiple NAD+ pathway points simultaneously produced greater NAD+ elevation than single-precursor supplementation, along with SIRT1 activation, reduced pro-inflammatory cytokines, and shifts toward younger biological age markers.

Community Voices

What people report

Anecdotal ReportNot medical evidence · Individual experience

"Started NMN at 500mg/day at 58. Within 6 weeks: noticeably better energy in the afternoons, sleep quality improved, and muscle recovery after training feels like it did a decade ago. Can't prove causation but I've taken it every day for 18 months and won't stop."

Male, 58, consistent long-term user. Energy and recovery improvements are the most consistently reported subjective effects. The difficulty of isolating NAD+ effects in people who are also eating well, exercising, and taking other supplements is a persistent interpretive challenge.

Anecdotal ReportNot medical evidence · Individual experience

"I had my NAD+ blood levels tested before and after 12 weeks of 500mg NMN daily. Levels went from 28 to 61 µmol/L. Whether that translates to anything meaningful I genuinely don't know — but at least I know it's working at the biochemical level."

Female, 44, using NAD+ blood testing to verify supplementation effects. Blood NAD+ testing has become increasingly available and popular among serious longevity-focused users. Baseline levels vary significantly by age, diet, and exercise status — making absolute targets difficult to define.

Benefits & Evidence

What the data shows

⚡

NAD+ elevation in blood and tissues

Multiple RCTs confirm oral NMN and NR reliably raise blood NAD+ levels in humans. Liposomal NMN shows superior elevation vs standard NMN in head-to-head trial (2025). This is the most consistently proven effect — the downstream health benefits are extrapolated from the NAD+ elevation.

● Strong — multiple RCTs

💪

Muscle insulin sensitivity and metabolic health

Yoshino (2022): 25% improvement in muscle insulin sensitivity vs placebo in premenopausal women with prediabetes. 2025 meta-analysis: NMN and NR improved skeletal muscle mass and function. 2023 RCT: reduced LDL, body weight, and diastolic blood pressure.

● Moderate — growing RCT base

🧠

Cognitive function and neurodegeneration

2024 RCT: NR in older adults with mild cognitive impairment — results variable but NR improved some cognitive markers. NAD+ depletion is strongly implicated in Alzheimer's disease models. Multiple trials in neurodegenerative disease underway. Emerging but not yet established in humans.

● Emerging — trials underway

🫀

Cardiovascular and vascular health

NMN reversed arterial endothelial dysfunction in old mice. 2023 human trial: reduced arterial stiffness. NR reduced inflammatory markers in older adults. The vascular evidence base in humans is growing but modest in scale.

● Moderate — small human trials

💤

Sleep quality and physical performance

2024 GeroScience RCT: NMN maintained walking speed and improved sleep quality in older adults. Resistance training raises muscle NAD+ and NAMPT — the lifestyle approach to NAD+ restoration with the strongest evidence base.

● Moderate — recent RCT

Safety First

Risks & considerations

Mild

Mild GI discomfort — occasional nausea, bloating, or loose stools at higher doses. Usually resolves with splitting doses or taking with food.

Mild

Niacin flush (niacin only) — hot, red, itching skin due to prostaglandin-mediated vasodilation. Not seen with NMN or NR. Specific to nicotinic acid (niacin) form. Dose-dependent and tolerability improves with continued use.

Moderate

Nicotinamide (niacinamide) at high doses — sirtuin inhibition: Plain nicotinamide raises NAD+ but also inhibits sirtuin enzymes at high concentrations — the opposite of what's intended for longevity purposes. Avoid high-dose nicotinamide as the primary NAD+ strategy.

Unknown

Long-term effects uncertain: Most RCTs are 8–24 weeks. Long-term NAD+ elevation effects in humans are not characterised. NAD+ also feeds cancer cell energy metabolism — whether supplementation affects cancer risk is an active research question without a clear answer.

Administration Routes

Oral, IV, IM & Intranasal

NAD+ precursors can be administered through multiple routes — each with different bioavailability, onset, cost, and clinical context. The route matters more for NAD+ than most supplements because oral bioavailability of direct NAD+ is very limited. Clinics and serious biohackers have moved increasingly toward parenteral routes for more reliable and rapid NAD+ elevation.

💊 Oral NMN / NR Most Accessible

Dose: NMN 250–1000mg daily · NR 300–1000mg daily. Take morning, with or without food.

Bioavailability: Moderate — NMN absorbed via Slc12a8 transporter in gut; NR converted to NMN before uptake. Liposomal formulations show significantly higher blood NAD+ elevation vs standard capsules in 2025 head-to-head trial.

Onset: Blood NAD+ elevates within hours; tissue effects over weeks. Confirm with NAD+ blood test at 8 weeks.

Best for: Daily maintenance supplementation, long-term longevity protocol. The most practical option for most people.

💉 IV NAD+ Infusion Clinic — Highest Bioavailability

Dose: 250–1000mg NAD+ in saline · infused over 1–4 hours · clinic administered.

Bioavailability: 100% — bypasses gut and first-pass metabolism entirely. Produces the highest and most rapid blood and tissue NAD+ elevation of any route. The gold standard for acute NAD+ restoration.

Onset: Blood NAD+ peaks during infusion. Effects — energy, mental clarity, reduced cravings — often reported during or immediately after infusion. Frequency: weekly to monthly depending on protocol.

Side effects: Flushing, nausea, and chest tightness if infused too rapidly — rate control is essential. Always physician or nurse administered. Best for: Acute restoration, addiction recovery programmes (established clinical use), post-illness recovery, and those wanting confirmed therapeutic-level NAD+ elevation.

🩺 IM Injection — NMN / NAD+ Clinic & Advanced Users

Dose: 100–500mg NMN or NAD+ in solution · IM gluteal or deltoid · 1–3× weekly.

Bioavailability: High — muscle absorption bypasses gut. Slower peak than IV but more sustained. Significantly more bioavailable than oral, particularly for direct NAD+. Volume per injection typically 1–2ml.

Onset: Blood NAD+ elevation within 30–60 minutes. More gradual than IV but meaningful elevation confirmed. Effects comparable to IV at equivalent doses in community reports.

Practical notes: Compounded NAD+ or NMN in sterile solution required — standard oral supplement powder not suitable for injection. Source from a compounding pharmacy. IM injection technique essential — see preparation guide. Best for: Those wanting parenteral NAD+ without clinic IV access. Weekly self-administered protocol alongside oral daily maintenance.

👃 Intranasal NMN Emerging · Community Use

Dose: 50–200mg NMN in nasal spray · once or twice daily · community-reported protocol.

Bioavailability: Theoretical advantage — nasal mucosa has direct access to systemic circulation and potentially to CNS via olfactory pathway. Bypasses gut conversion steps. Limited formal bioavailability data vs oral for NMN specifically.

Rationale: NMN must enter cells to become NAD+. Intranasal delivery may offer preferential CNS and brain NAD+ elevation — potentially relevant for cognitive and neurological applications where oral precursors may have limited brain penetration. Growing interest in nootropic community.

Practical notes: Requires properly formulated nasal spray — not simply dissolving oral powder. pH must be appropriate for nasal mucosa. Human evidence is limited — this is community-level experimentation rather than established practice. Best for: Those specifically targeting cognitive or neuroprotective applications and wanting potential CNS-directed NAD+ elevation.

Route comparison summary: Oral NMN/NR → daily maintenance, most accessible, moderate bioavailability. IM → weekly parenteral top-up, high bioavailability, self-administered. IV → monthly or as-needed acute restoration, maximum bioavailability, clinic-administered. Intranasal → potentially CNS-targeted, community-stage, limited formal data. Most serious longevity protocols combine oral daily + periodic IV or IM for deeper tissue NAD+ restoration. Always use properly formulated, sterile preparations for any parenteral route — oral supplement powder is not suitable for injection under any circumstances.

Synergy Stack

Nutrients, Supplements & Exercise

NAD+ sits at the centre of multiple metabolic pathways. The synergy stack targets the enzymes and co-factors that determine how effectively elevated NAD+ translates into health benefits.

💊 Nutrients & Supplements

NMN or NR (the core)

250–500mg/day NMN · 300–600mg/day NR

Moderate evidence

NMN and NR are interchangeable in most protocols — NMN is marginally closer to NAD+ in the pathway; NR is more extensively studied. Liposomal forms show superior blood elevation in head-to-head trials. Take in the morning — NAD+ metabolism is circadian and morning dosing aligns with natural rhythms.

Resveratrol

500mg/day with fat-containing meal

Moderate evidence

Sirtuin activator — specifically SIRT1 agonist. The Sinclair longevity stack combines NMN + resveratrol on the rationale that NMN provides the NAD+ substrate and resveratrol activates the sirtuin enzymes that use it. Animal data strong; human longevity data still emerging.

Apigenin (CD38 inhibitor)

50–100mg/day

Limited evidence

CD38 is an enzyme that consumes NAD+ — its activity increases with age, contributing to NAD+ decline. Apigenin (found in parsley, chamomile) inhibits CD38, theoretically preserving NAD+ for sirtuins. Limited human data but mechanistically rational as part of a multi-pronged NAD+ strategy.

Tryptophan-rich diet

Adequate dietary tryptophan

Moderate evidence

Tryptophan is a de novo NAD+ precursor via the kynurenine pathway. Dietary protein adequacy supports this alternative NAD+ synthesis route, complementing precursor supplementation. Prioritise complete protein sources throughout the day.

🏃 Exercise & Lifestyle — the most powerful NAD+ interventions

Exercise — the best NAD+ booster

Resistance training and aerobic exercise both raise muscle NAD+ levels and NAMPT (the rate-limiting enzyme in NAD+ synthesis) — often more effectively than supplementation in people with baseline adequate fitness. A 2025 study confirmed acute exercise boosts NAD+ metabolism in peripheral blood. Exercise may be the most evidence-backed NAD+ intervention available, and it's free.

Intermittent fasting / caloric restriction

Fasting activates AMPK, which activates NAMPT, which increases NAD+ synthesis — and also activates sirtuins through reduced NAD+ consumption during the fast. The NAD+ → sirtuin axis is a key mechanism behind caloric restriction's longevity effects in multiple model organisms.

Alcohol reduction

Alcohol metabolism consumes NAD+ extensively — alcohol dehydrogenase and aldehyde dehydrogenase both require NAD+ as a cofactor, generating NADH and depleting the NAD+ pool. Regular alcohol consumption is one of the most reliably modifiable lifestyle factors depleting NAD+.

⏱ Timing & Protocol Notes

NMN or NR: morning, with or without food (food may improve tolerability). Resveratrol: with a fat-containing meal (fat-soluble). Apigenin: any time. NAD+ blood level testing at baseline and 8 weeks post-supplementation to confirm response. Target: blood NAD+ meaningfully above age-typical baseline. Exercise and dietary protein: non-negotiable co-interventions.

The honest bottom line: Regular exercise and reducing alcohol are the most evidence-backed NAD+ interventions available to most people. NMN and NR supplementation adds on top — reliably raising blood NAD+, with metabolic and physical performance benefits in human RCTs. Both approaches together is the optimal strategy.

Honest Assessment

Editor's summary

NAD+ biology is one of the most compelling areas of longevity science — the mechanism connecting NAD+ decline to hallmarks of ageing is genuinely well-supported at the basic science level. The human clinical evidence, while still maturing, is now substantial enough to be taken seriously: multiple RCTs confirm NAD+ elevation, metabolic improvements, muscle benefits, and vascular health improvements. The safety profile is excellent.

The honest caveat: the direct line from raised blood NAD+ to meaningfully longer or healthier lives in humans has not been established. The mechanism strongly suggests benefit; the human outcome data is encouraging but not definitive. Most longevity researchers treat NMN/NR as a reasonable bet with a strong mechanistic rationale and an acceptable risk profile — rather than a proven intervention.

The most underappreciated point: regular exercise and reduced alcohol consumption are probably more powerful NAD+ interventions than any supplement — and they have decades of human outcome data behind them. Use both approaches together.

Verdict

"One of the most mechanistically compelling longevity supplements available. Reliably raises NAD+ in humans, with metabolic and muscle benefits in RCTs. The direct longevity evidence in humans is still emerging. Safe, well-tolerated, and rational — especially alongside the lifestyle interventions that raise NAD+ most powerfully: exercise and alcohol reduction."